Android Apple

FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships

By Yahoo! Finance   |   1 month ago
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships

Iterum Therapeutics plc received FDA approval for Orlynvah to treat uncomplicated urinary tract infections in adult women. This marks a significant milestone for Iterum and offers a new treatment option for patients.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.